Ensysce Biosciences Inc Sustainability Reports

Ensysce Biosciences, Inc. is a clinical-stage biotech company developing a new class of safer prescription opioid drugs. Its proprietary technology platforms are designed to reduce the risk of drug abuse and prevent accidental or intentional overdoses.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG00JFF4183

No reports are currently available in our catalogue.